In this review article we present the evidence to date supporting the role of the calcium-sensing receptor (CaSR) as a key, pluripotential molecular trigger for asthma and speculate on the… Click to show full abstract
In this review article we present the evidence to date supporting the role of the calcium-sensing receptor (CaSR) as a key, pluripotential molecular trigger for asthma and speculate on the likely benefits of topical therapy of asthma with negative allosteric modulators of the CaSR: calcilytics. Negative allosteric modulators of the calcium-sensing receptor (calcilytics) delivered topically to the airways have the potential to revolutionise asthma therapy https://bit.ly/3tdSZkC
               
Click one of the above tabs to view related content.